Get the Stockscreener App
38.02
1.39%
0.52
After Hours:
37.60
-0.42
-1.10%
Eton Pharmaceuticals Inc stock is traded at $38.02, with a volume of 369.67K.
It is up +1.39% in the last 24 hours and up +30.52% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$37.50
Open:
$37.44
24h Volume:
369.67K
Relative Volume:
0.89
Market Cap:
$1.04B
Revenue:
$86.93M
Net Income/Loss:
$-1.48M
P/E Ratio:
-536.25
EPS:
-0.0709
Net Cash Flow:
$431.00K
1W Performance:
+3.51%
1M Performance:
+30.52%
6M Performance:
+129.45%
1Y Performance:
+163.11%
1-Day Range:
$37.44
$38.57
1-Week Range:
$35.95
$38.57
52-Week Range:
$13.76
$38.57
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
38.02 | 991.60M | 86.93M | -1.48M | 431.00K | -0.0709 |
TAK
Takeda Pharmaceutical Co Adr
|
16.89 | 50.65B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.72 | 41.09B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.29 | 39.45B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
75.42 | 30.13B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
547.25 | 23.00B | 3.17B | 1.29B | 1.01B | 27.09 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Reiterated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | B. Riley Securities | Buy |
| Jan-06-25 | Reiterated | H.C. Wainwright | Buy |
| Sep-04-24 | Resumed | H.C. Wainwright | Buy |
| May-06-24 | Initiated | Craig Hallum | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
View All
Eton Pharmaceuticals Inc Stock (ETON) Latest News
Precision Trading with Eton Pharmaceuticals Inc. (ETON) Risk Zones - Stock Traders Daily
Enterprise value to revenue forward of Eton Pharmaceuticals, Inc. – NASDAQ:ETON - TradingView
Form 4 Eton Pharmaceuticals Inc For: 30 June By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals (ETON) CBO awarded 10,000 restricted stock units - Stock Titan
Eton Pharmaceuticals stock hits all-time high at 36.97 USD - Investing.com
Enterprise value to revenue forward of Eton Pharmaceuticals, Inc. – BOATS:ETON - TradingView
Price to sales forward of Eton Pharmaceuticals, Inc. – NASDAQ:ETON - TradingView
Price to book forward of Eton Pharmaceuticals, Inc. – BOATS:ETON - TradingView
Enterprise value to EBIT forward of Eton Pharmaceuticals, Inc. – NASDAQ:ETON - TradingView
Price to sales forward of Eton Pharmaceuticals, Inc. – BOATS:ETON - TradingView
Enterprise value to EBITDA forward of Eton Pharmaceuticals, Inc. – BOATS:ETON - TradingView
Form 144 Eton Pharmaceuticals For: 26 June By Investing.com - Investing.com Australia
ETON (ETON) Form 144: Affiliate sales include 25,000-share disposals - Stock Titan
Eton Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:ETON) - TradingView
ETON Forecast — Price Target — Prediction for 2027 - TradingView
Form 144 Eton Pharmaceuticals For: 25 June By Investing.com - Investing.com Nigeria
ETON (NASDAQ: ETON) notice: Director proposes sale of 25,000 shares - Stock Titan
Eton Pharmaceuticals, Inc. (ETON) misses Q1 earnings estimates - MSN
Eton Pharmaceuticals Inc (ETON) Institutional Confidence - TradingKey
Eton Pharmaceuticals Inc (ETON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Form 144 Eton Pharmaceuticals For: 23 June By Investing.com - Investing.com South Africa
Insider files to sell 25,000 shares via option exercise | ETON SEC FilingForm 144 - Stock Titan
Eton Pharmaceuticals, Inc.(NasdaqGM:ETON) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Eton Pharmaceuticals StockLong-term strategy in rare disease drugs - Ad-hoc-news.de
Eton Pharmaceuticals director Adams sells 50,000 shares for $1.62m By Investing.com - Investing.com Australia
Eton Pharmaceuticals director Adams sells 50,000 shares for $1.62m - Investing.com UK
Eton Pharmaceuticals Insider Sold Shares Worth $1,623,795, According to a Recent SEC Filing - marketscreener.com
Eton Pharmaceuticals Director Sold Shares Worth Over $1.6M - TradingView
Eton Pharmaceuticals (ETON) director exercises options, sells 50,000 shares in open market - Stock Titan
[144] Eton Pharmaceuticals, Inc. SEC Filing - Stock Titan
Eton Pharmaceuticals Inc (ETON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Eton Pharmaceuticals Inc (ETON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ETON Stock Price, Quote & Chart - ChartMill
Eton Pharmaceuticals (ETON) surges 19.8%: Is this an indication of further gains? - MSN
Eton Pharmaceuticals (ETON) Surges 4.75% as Momentum Builds Toward ResistanceWatchlist Stock Ideas - newsline.com
Trading the Move, Not the Narrative: (ETON) Edition - Stock Traders Daily
Eton Pharmaceuticals (NASDAQ: ETON) 2026 vote supports board and auditor - Stock Titan
Eton Pharmaceuticals (ETON) Gains 2.8% as Bullish Momentum Builds Toward ResistanceHigh Beta Stocks - newsline.com
Eton Pharmaceuticals Rallies as Stock Approaches Key Resistance (ETON)Total Put Call - newsline.com
Eton Pharmaceuticals (ETON) Holds Steady Near Resistance With Modest GainDividend ETF - newsline.com
ETON Q1 2026 Earnings: EPS Misses Estimates Despite Narrow ProfitCore Business Growth - newsline.com
Possible Bearish Signals With Eton Pharmaceuticals Insiders Disposing Stock - simplywall.st
ETON: Aggressively scaling rare disease portfolio with strong sales, margin growth, and patient focus - TradingView
Eton Pharmaceuticals (ETON) CFO reports 37,000 employee stock options - Stock Titan
Eton Pharmaceuticals CEO Sean Brynjelsen sells $3.83 million in stock - Investing.com India
Eton Pharmaceuticals Inc (ETON) Shares Fall 4.3% -- What GF Scor - GuruFocus
Eton Pharmaceuticals CEO Sean Brynjelsen sells $3.83 million in stock By Investing.com - Investing.com South Africa
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.03%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):